from Roth Capital issued a price target of $15.00 for ORN on 2026-07-30 14:00:09.The adjusted price target was set to $15.00.At the time of the announcement, ORN...
from UBS issued a price target of $6.00 for TRVG on 2026-07-30 11:30:03.The adjusted price target was set to $6.00.At the time of the announcement, TRVG was...
from Cantor Fitzgerald issued a price target of $3.50 for CAPR on 2026-07-29 22:19:55.The adjusted price target was set to $3.50.At the time of the announcement, CAPR...
from Piper Sandler issued a price target of $15.50 for WNEB on 2026-07-29 11:59:44.The adjusted price target was set to $15.50.At the time of the announcement, WNEB...
from UBS issued a price target of $9.50 for TZOO on 2026-07-29 11:37:31.The adjusted price target was set to $9.50.At the time of the announcement, TZOO was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...